(BEAM) Beam Therapeutics - Performance -18.2% in 12m
BEAM performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-38.83%
#55 in Peer-Group
Rel. Strength
29.02%
#5449 in Stock-Universe
Total Return 12m
-18.24%
#72 in Peer-Group
Total Return 5y
-15.46%
#39 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 34.09 USD |
| 52 Week Low | 14.54 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 91.26 |
| Buy/Sell Signal +-5 | -0.04 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: BEAM (-18.2%) vs XBI (-11.1%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
1.02% | 61.8% | 74.7% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
6.89% | -8.76% | 155% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
1.19% | -6.24% | 38% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-2.29% | 26.9% | -2.56% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
7.48% | -8.9% | 5.85% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
11.5% | 27.6% | -6.21% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.47% | 46.2% | -8.05% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
1.64% | 26.9% | 19% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: BEAM vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for BEAM
| Total Return (including Dividends) | BEAM | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 18.28% | 3.15% | 4.01% |
| 3 Months | 36.78% | 17.08% | 17.14% |
| 12 Months | -18.24% | -11.14% | 13.46% |
| 5 Years | -15.46% | -21.96% | 112.73% |
| Trend Score (consistency of price movement) | BEAM | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 69.8% | 52.1% | 90.3% |
| 3 Months | 7.2% | 79.4% | 97.5% |
| 12 Months | -57.8% | -87.4% | 46.4% |
| 5 Years | -69.2% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th87.50 | 14.67% | 13.72% |
| 3 Month | %th72.50 | 16.82% | 16.76% |
| 12 Month | %th64.00 | -7.99% | -27.94% |
| 5 Years | %th80.50 | 8.32% | -60.26% |
FAQs
Does Beam Therapeutics (BEAM) outperform the market?
No,
over the last 12 months BEAM made -18.24%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.14%.
Over the last 3 months BEAM made 36.78%, while XBI made 17.08%.
Performance Comparison BEAM vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
BEAM vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 9.9% | 14.3% | -25.1% | -32% |
| US NASDAQ 100 | QQQ | 9.9% | 14.1% | -27.1% | -32% |
| German DAX 40 | DAX | 9.5% | 17.1% | -37.2% | -48% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 8.7% | 13.7% | -29.5% | -37% |
| Hongkong Hang Seng | HSI | 9% | 15.5% | -47.1% | -53% |
| India NIFTY 50 | INDA | 11.2% | 19.1% | -25.5% | -15% |
| Brasil Bovespa | EWZ | 14.1% | 18.9% | -40.1% | -20% |
BEAM vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 11.3% | 16.6% | -28.4% | -42% |
| Consumer Discretionary | XLY | 8.9% | 14.9% | -17.4% | -36% |
| Consumer Staples | XLP | 11.9% | 18.4% | -24.1% | -26% |
| Energy | XLE | 6.9% | 14.2% | -17.5% | -20% |
| Financial | XLF | 11.3% | 15.7% | -27.4% | -44% |
| Health Care | XLV | 9.7% | 18.2% | -13.6% | -12% |
| Industrial | XLI | 9.5% | 13.8% | -30.9% | -42% |
| Materials | XLB | 9.2% | 13.8% | -25.7% | -22% |
| Real Estate | XLRE | 10.1% | 18.4% | -23.5% | -26% |
| Technology | XLK | 10% | 11.7% | -30.2% | -29% |
| Utilities | XLU | 9.8% | 15.7% | -29.1% | -38% |
| Aerospace & Defense | XAR | 9.2% | 11.4% | -45% | -67% |
| Biotech | XBI | 6.2% | 15.1% | -14.8% | -7% |
| Homebuilder | XHB | 6.8% | 9.5% | -18.5% | -17% |
| Retail | XRT | 9.9% | 15% | -20.2% | -25% |
BEAM vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 9.3% | 15.0% | -11.1% | -14% |
| Natural Gas | UNG | 11.6% | 24.7% | 1% | -16% |
| Gold | GLD | 9.7% | 18% | -43% | -57% |
| Silver | SLV | 5.5% | 12% | -47.1% | -40% |
| Copper | CPER | -0.5% | 3.3% | -44.6% | -42% |
BEAM vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 10.7% | 18.3% | -19.7% | -14% |
| iShares High Yield Corp. Bond | HYG | 10.4% | 17.2% | -22.1% | -27% |